Sputum colour as a simplified effective biomarker for clinical assessment of bronchiectasis.

Eur Respir J

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Respiratory and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical Univer

Published: April 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00152-2024DOI Listing

Publication Analysis

Top Keywords

sputum colour
4
colour simplified
4
simplified effective
4
effective biomarker
4
biomarker clinical
4
clinical assessment
4
assessment bronchiectasis
4
sputum
1
simplified
1
effective
1

Similar Publications

[Research progress on bedside sputum assessment].

Zhonghua Jie He He Hu Xi Za Zhi

August 2025

Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Diseases, Chinese Academy of Medical Sciences, National Clinical Medical Research Center for Respiratory Diseases, Beijing 100029, China.

Respiratory infections have a high incidence rate globally. As an important biological specimen that is routinely monitored in the respiratory system, the physical properties of sputum can reflect the pathophysiological state of the respiratory system and are therefore significant in the diagnosis and prognosis of respiratory diseases. This article reviewed the research progress on bedside assessment of sputum, focusing on the assessment methods of three core dimensions: sputum color, viscosity, and volume.

View Article and Find Full Text PDF

Purpose: Chronic Obstructive Pulmonary Disease (COPD) remains a challenging condition to manage due to its variability in clinical presentation and progression. While the disease control is a well-defined concept in asthma, its relevance in COPD is less clear. This study aimed to evaluate the clinical utility of COPD control framework, developed in Spain, in Portuguese outpatients by analyzing exacerbation rates among controlled and uncontrolled patients.

View Article and Find Full Text PDF

Acute Respiratory Infections (ARIs) are a leading cause of pediatric mortality, with Pseudomonas aeruginosa as a key pathogen. This study evaluated Recombinase Polymerase Amplification (RPA)-ELISA for rapid detection of P. aeruginosa in respiratory samples (n = 101).

View Article and Find Full Text PDF

The interplay between symptom deterioration of chronic obstructive pulmonary disease and chronic heart failure.

Heart Lung

June 2025

Health Technology & Services Research, TechMed Centre, University of Twente, Enschede, Netherlands; Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, Netherlands; Clinical Research Center, Rijnstate Hospital, Arnhem, Netherlands. Electronic address:

Background: Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) commonly co-exist and share symptoms, which complicates disease management. It is unclear how COPD and CHF deterioration inter(re)act.

Objective: This study aimed to assess the interplay between COPD and CHF deterioration on group and individual level.

View Article and Find Full Text PDF

Patients with chronic obstructive pulmonary disease (COPD) often experience acute exacerbations characterized by elevated neutrophilic inflammation in the lungs. Currently, this condition is diagnosed through visual inspection of sputum color and volume, a method prone to personal bias and unsuitable for patients who are unable to expectorate spontaneously. In this manuscript, we present a novel approach for measuring and monitoring exhaled myeloperoxidase (MPO), a biomarker of neutrophilic airway inflammation, without the need for sputum analysis.

View Article and Find Full Text PDF